European Healthcare Analysts hold a conference call with management to discuss the near-term growth drivers of Novartis’ blockbuster cardio-renal franchise and the longer-term potential pipeline opportunities on September 4 at 9 am hosted by Jefferies. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NVS:
- Novartis participates in a conference call with Jefferies
- Novartis shares rising but challenges remain, WSJ reports
- Biden unveils first 10 drugs subject to Medicare price negotiation
- Novartis presents new long-term Leqvio data
- Novartis’ (NYSE:NVS) Sandoz Bags FDA Approval for Multiple Sclerosis Treatment